SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-075217
Filing Date
2021-06-01
Accepted
2021-06-01 19:01:39
Documents
1
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2118118-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2118118-4_4seq1.xml 4 6203
  Complete submission text file 0001104659-21-075217.txt   7694
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O BAXALTA INCORPORATED 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address
ROSA-BJORKESON DAGMAR (Reporting) CIK: 0001643934 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 21987062